Clinical trial
Retrospective Study That Evaluate the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Patients With Primary Sjogren Syndrome
NCT02381587 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Study That Evaluate the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Patients With Primary Sjogren Syndrome
- Lead sponsor
- Meir Medical Center
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 30, 2015
- Completion date
- April 30, 2016
- Enrollment
- 500 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
primary sjogren syndrome with multisystem involvement